NMN can regulate lipid metabolism and improve various chronic diseases caused by obesity

According to the "Report on the Status of Nutrition and Chronic Diseases of Chinese Residents (2020)", more than half of the adult residents in China are overweight and obe.
The overweight rate of adult residents (≥18 years old) is 33% and the obesity rate is 1
Obesity has become an epidemic, causing many chronic and metabolic diseases, including diabetes and cardiovascular disea.
Recently, Professor Mika Kivimöki and her team from University College London, UK, based on clinical research data of more than 100,000 people, found that obesity is closely related to 21 diseases such as cardiovascular metabolism, digestion, respiratory, neurological, musculoskeletal and infectious diseas.
relat.
In the obese population, the risk of having ≥4 obesity-related diseases (complex comorbidities) was approximately 139 times that of the normal-weight population, and the age of onset was significantly earli.
This conclusion was further validated in an independent cohort of the UK bioba.
The article was recently published in The Lancet Diabetes & Endocrinolo.
Fortunately, obesity is a reversible causative factor that we can reverse through daily diet and exerci.
However, a large number of clinical data prove that eating less and exercising more has a limited effect on most severely obese people, who are still suffering from the health risks and psychological distress caused by obesi.
Based on the known beneficial effects of exercise on obesity metabolism, scientists conducted related resear.
In 2017, a team led by Professor Margaret.
Morris of the University of New South Wales School of Medicine conducted a series of studies on the role of NMN in weight management and found that for genetically obese mice, both NMN and exercise can reduce obesity and make glucose toleran.
Sexual and mitochondrial function improv.
In March 2020, the team of Professor Sinclair, a well-known anti-aging scholar at Harvard University, found that long-term intake of NMN can regulate metabolic disorders caused by maternal obesity, and significantly improve blood sugar regulation, liver fat content and body weig.

In 2021, the first clinical trial of NMN published by Professor Shinichiro Imai's team in Science also confirmed that NMN can improve glucose tolerance in women with prediabet.

On April 14, 2021, the famous scientific journal "Scientific Reports" published a new research progress in the field of NMN, which once again confirmed this point: after supplementing NMN, the activity of "longevity protein" SIRT1 in lipid cells will be greatly increas.

, This change will not only optimize the metabolic state of key proteins, but also directly affect the mitochondrial function of lipid cells, so that the health of lipid cells can be improved in an all-round way, and the accumulation of fat caused by abnormal lipid metabolism can be eliminat.

and obesi.

Researchers have verified the effectiveness of NMN in improving obesity and regulating lipid metabolism from three aspects: genetic factors, metabolic disorders and clinical tria.

This series of studies shows that NMN has broad application prospects in the field of weight manageme.

NMN may become a key target to control fat burning, help obese people get rid of obesity, and improve obesity-related diseas.